Leland Gershell
Analyst
Oppenheimer
Equibles does not estimate personal net worth.
About Leland Gershell
Leland Gershell is recorded as Analyst at Oppenheimer. Leland Gershell has spoken on 3 earnings calls across 3 companies, most recently for Ligand Pharmaceuticals Inc on August 6, 2026. Those appearances were for Ligand Pharmaceuticals Inc (LGND), Soleno Therapeutics Inc and Viridian Therapeutics, Inc.\DE (VRDN). The companies whose calls Leland Gershell spoke on are classified in the Healthcare sector.
Leland Gershell on recent calls
“And adding my congratulations as well to Todd and the team. A couple questions from us.”
“And, Jim, just wanted to add my sentiments as well. Wish you all the best as you move on.”
“It sounds like encouraging progress on the subcutaneous possibility for 001. I wanted to get further color on where you think you are in that opportunity. Do you think you need more development of the subcutaneous formulation, or is it just a matter of more testing and evaluation?”
Affiliation history
-
Oppenheimer
Analyst
Source not stated
Current
Company network
Soleno Therapeutics Inc
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-02-25
Recent activity
-
-
Earnings call
Soleno Therapeutics Inc Q4 FY2025 Earnings Call
Soleno Therapeutics Inc
-